Titre :
  • Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma.
Auteur : Bachet, Jean-Baptiste ; Marechal, Raphaël ; Demetter, Pieter ; Bonnetain, F ; Couvelard, Anne ; Svrcek, Magali ; Bardier-Dupas, Armelle ; Hammel, P ; Sauvanet, Alain ; Louvet, C ; Paye, François ; Rougier, Philippe ; Penna, C ; Vaillant, J C ; André, T ; Closset, Jean ; Salmon, Isabelle ; Emile, Jean-François ; Van Laethem, Jean-Luc
Informations sur la publication : Annals of oncology, 23, 9, (page 2327-2335)
Statut de publication : Publié, 2012-09
Sujet CREF : Sciences humaines
Mots-clés : Adjuvant chemotherapy
CXCR4
LKB1
Pancreatic adenocarcinoma
Smad4
Type II TGF-β receptor
Mots-clés MeSH : Adenocarcinoma -- metabolism -- mortality -- secondary -- therapy
Adult
Aged
Aged, 80 and over
Chemotherapy, Adjuvant
Disease Progression
Female
Humans
Kaplan-Meier Estimate
Lymphatic Metastasis
Male
Middle Aged
Multivariate Analysis
Pancreatic Neoplasms -- metabolism -- mortality -- pathology -- therapy
Proportional Hazards Models
Prospective Studies
Receptors, CXCR4 -- metabolism
Smad4 Protein -- metabolism
Treatment Outcome
Tumor Markers, Biological -- metabolism
Note : Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0923-7534 
info:doi/10.1093/annonc/mdr617
info:pii/mdr617
info:pmid/22377565